Author:
Rea Bryan,Aggarwal Nidhi,Yatsenko Svetlana A.,Bailey Nathanael,Liu Yen-Chun
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference34 articles.
1. Sole F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luno E, et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol. 2000;108:346–56.
2. Jerez A, Gondek LP, Jankowska AM, Makishima H, Przychodzen B, Tiu RV, et al. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. J Clin Oncol. 2012;30:1343–9.
3. Mallo M, Cervera J, Schanz J, Such E, Garcia-Manero G, Luno E, et al. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Leukemia. 2011;25:110–20.
4. Hasserjian RP, Le Beau MM, List AF, Bennett JM, Brunning RD, Thiele J. Myelodysplastic syndrome with isolated del(5q). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised. 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 115–6.
5. Ebert BL. Molecular dissection of the 5q deletion in myelodysplastic syndrome. Semin Oncol. 2011;38:621–6.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献